**EVENTO AO VIVO!!**

====EXCEPCIONALMENTE ABERTO A TODOS - NECESSÁRIO LOGIN PARA ASSISTIR A AULA====

*ESTE EVENTO POSSUI PONTUAÇÃO NO CNA

**CERTIFICADOS SÓ SERÃO DISPONIBILIZADOS PARA AQUELES QUE FIZEREM LOGIN E RESPONDEREM A PESQUISA DE SATISFAÇÃO**
***SÓ SERÃO EMITIDOS CERTIFICADOS PARA AQUELES QUE ASSISTIREM AO VIVO***

Highlights do ACC - Parte II
Data: 10/04
Horário: 19h00 às 20h30

**Programa:
19h00 - Zilebesiran in Combination With a Standard-of-care Antihypertensive in Patients With Inadequately Controlled Hypertension: Primary Results From the Phase 2 Kardia-2 Study
Dra. Fernanda Marciano Consolim-Colombo (aguardando retorno dos slides do estudo)
19h10 - A Clinical Trial to Evaluate the Influence of a Spirituality Intervention on Blood Pressure Control, Central Hemodynamics and Endothelial Function: The Feel Trial
Dr. Alvaro Avezum
19h20 - Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results of IMPROVE-HCM
Dr. Felix Jose Alvarez Ramires (aguardando retorno dos slides do estudo)
19h30 - Preventing Cardiac Damage in Patients Treated For Breast Cancer and Lymphoma: A Phase 3 Randomized, Open Label, Blinded Endpoint, Superiority Trial of Enalapril to Prevent Anthracycline-induced Cardiotoxicity (PROACT)
Dra. Ariane Vieira Scarlatelli Macedo
19h40 - Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients at Low to Intermediate Risk: One Year Outcomes of the Randomized DEDICATE-DZHK6 Trial
Dr. Henrique Barbosa Ribeiro
19h50 - Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Multicenter, Randomized, Blinded, IVUS-ACS Trial
Dr. Marcelo José de Carvalho Cantarelli